Physician

Mark K Yamaguchi, M.D.

According to 2025 Medicare claims, Mark Yamaguchi, M.D. (NPI: 1033313580) practices interventional pain management (ipm) in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from St. Croix, WI. This provider's primary affiliated billing organization is TRIA ORTHOPAEDIC CENTER LLC (NPI: 1518273085; TIN: 200034003) and primary practice location at 54016-7848. Yamaguchi is affiliated with the Park Nicollet Health Services ACO LLC d/b/a HealthPartners ACO (ACO ID: D0207), participating under the REACH model.

Yamaguchi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 217 traditional Medicare patients, billed 1,485 HCPCS/CPT codes, and received $66,490 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 507 prescription claims across 164 beneficiaries totaling $15,486 in drug costs, led by Lidocaine (Lidocaine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $23,289 to $66,490. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $20,642 and ending at $15,486. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	171	364	$23,289
2016	179	321	$21,579
2017	121	252	$14,823
2018	100	203	$12,426
2019	108	230	$14,734
2020	78	226	$13,074
2021	69	249	$22,707
2022	124	369	$26,699
2023	177	1,290	$48,251
2024	217	1,485	$66,490

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	419	$20,642
2016	116	418	$22,802
2017	124	499	$38,886
2018	77	259	$16,097
2019	52	128	$4,847
2020	138	498	$15,689
2021	106	589	$21,264
2022	80	197	$4,587
2023	103	348	$8,241
2024	164	507	$15,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	56	64	$183
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	90	90	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	139	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	57	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	107	157	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine	Lidocaine	19	780	$2,140
Gabapentin	Gabapentin	114	4,488	$1,690
Tizanidine Hcl	Tizanidine Hcl	89	2,513	$1,488
Fentanyl	Fentanyl	11	330	$904
Pregabalin	Pregabalin	37	1,700	$817

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark K. Yamaguchi, M.D.?

Tedicare shows public-source Medicare data for Mark K. Yamaguchi, M.D. (NPI 1033313580), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark K. Yamaguchi, M.D. have ACO affiliation data?

Mark K. Yamaguchi, M.D. is shown with ACO affiliation data for Park Nicollet Health Services ACO LLC d/b/a HealthPartners ACO (REACH, ACO ID D0207).

What billing organization is linked to Mark K. Yamaguchi, M.D.?

Mark K. Yamaguchi, M.D. is linked to TRIA ORTHOPAEDIC CENTER LLC (billing NPI 1518273085) in the available physician profile data.

Does Mark K. Yamaguchi, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.